EUVIMEDEUVIMED entdecken
CrossrefInfokarte

HEARING LOSS IN PATIENTS WITH COVID-19

Gökmen ÖZCEYLAN, Dilek TOPRAK

SDÜ Tıp Fakültesi Dergisi · 2022

DOI: 10.17343/sdutfd.1070586 ↗
AbstractBibliografische Angaben

Abstract

Objective Worldwide, scientists continue to follow-up on patients recovered from COVID-19 and have published the long-term persistent symptoms and permanent damage observed in various tissues. The present study aimed to evaluate hearing loss in patients with COVID-19 on the basis of pure tone averages measured using pure tone audiometry. Material and Method In this retrospective data analysis study, pure tone averages of non-hospitalised patients with COVID-19 were compared over 1 year before and after contracting COVID-19. Continuous variables were presented as mean ± Standard deviation (SD) and categorical variables were presented as number (n) and percentage (%). All data showed normal distribution. Therefore, paired t-test, a type of parametric test, was used to identify the significant differences between the measurements. Results The pure tone threshold values of patients increased significantly after COVID-19 (p0.001 for all) based on puretone averages measured in the bones and airways of theleftandrightears. Olderadults (41–64 yearsold) had a greater difference in puretone averages of the left ear airway before and after COVID-19 (p=0.040) than younger adults (18–40 yearsold). Conclusion COVID-19 affects both ears' bones and airways, causing varying degrees of hearing loss at different frequencies. Hearing loss tests should be included in COVID-19 complications research, and clinicians should be given advice on how to avoid hearing loss.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →